Modified lentiviral globin gene therapy for pediatric β0/β0 transfusion-dependent β-thalassemia: A single-center, single-arm pilot trial
Shiqi Li(nLIGHT (United States)), Yujia Cai(Shanghai Jiao Tong University), Wei Tang(Zhejiang University of Technology), Sikai Ling(Shanghai Jiao Tong University), Yingnian Chen, Zhongtao Yuan, Ying Dai, Sanbin Wang, Xiaoyuan Wang(Regend Therapeutics (China)), Lihua Zhang(Regend Therapeutics (China)), Dawei Wang(RWTH Aachen University), Lin Liu, Le Luo, Fangyuan Hao(Regend Therapeutics (China)), Sujiang Zhang(Shanghai Institute of Hematology), Lin Zhang(The University of Melbourne), Yu Li, Liufan Yin, Dongjie Deng, Lvzhe Chen
Cited by 77
Related Papers
Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study
|Cancers|2022|303
Updated epidemiology of gastrointestinal cancers in East Asia
|Nature Reviews Gastroenterology & Hepatology|2023|258
The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends
|The Lancet Haematology|2022|208
Targeting herpes simplex virus with CRISPR–Cas9 cures herpetic stromal keratitis in mice
|Nature Biotechnology|2021|178
Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis
|Journal of Hematology & Oncology|2022|137